Cleansing Notice

100311307/1581272.3
MEDIA RELEASE

26 November 2020


CLEANSING NOTICE – SIMPLIFIED DISCLOSURE OFFER FOR THE ISSUE OF
FINANCIAL PRODUCTS


Ryman Healthcare Limited (Ryman) gives notice under regulation 49G(2)(e) of the Financial
Markets Conduct Regulations 2014 (Regulations) that it proposes to make an offer for the
issue of fixed rate, secured, unsubordinated bonds (Bonds).

Short-form disclosure is being used for the offer of the Bonds, as the Bonds will rank in
priority to Ryman’s existing ordinary shares quoted on the NZX Main Board under ticker code
RYM. Ryman’s shares have been continuously quoted on the NZX Main Board over the
preceding three months and trading in its shares has not been suspended for a total of more
than five trading days during that three month period.

As at the date of this notice, Ryman is in compliance with:

(a) the continuous disclosure obligations that apply to it in relation to its existing ordinary
shares quoted on the NZX Main Board; and

(b) its financial reporting obligations (as defined in regulation 49H(7) of the Regulations).

As at the date of this notice, there is no information that is “excluded information” required
to be disclosed for the purposes of regulation 49H(2)(e) of the Regulations.

Joint Lead Managers



0800 269 476 0800 367 227




0800 742 737 0800 942 822
ENDS

For investor relations information contact Michelle Perkins, Investor Relations Manager, on 027
222 9684 (+64 27 222 9684) or email michelle.perkins@rymanhealthcare.com
For media information or images contact David King, Corporate Affairs Manager, on 021 499 602
(+64 21 499 602) or email david.king@rymanhealthcare.com